Register
Login:
Share:
Email Facebook Twitter

EXCLUSIVE: Malcy, Columbus & Reabold presentations - Video Webcast Here

EXCLUSIVE: Leo Koot, Exec Chairman, Columbus Energy speaks at London South East's Oil & Gas event
EXCLUSIVE: Stephen Williams, Reabold Resources speaks at London South East's Oil & Gas event


Astrazeneca Regulatory News (AZN)



Regulatory News for Astrazeneca (AZN)


Share Price: 5,589.00Bid: 5,591.00Ask: 5,593.00Change: 0.00 (0.00%)No Movement on Astrazeneca
Spread: 2.00Spread as %: 0.04%Open: 5,613.00High: 5,642.00Low: 5,540.00Yesterday’s Close: 5,589.00





DateSourceHeadlineCategory
18-Jul-18 16:11RNSHolding(s) in CompanyHolding(s) in Company
18-Jul-18 12:00RNSHolding(s) in CompanyHolding(s) in Company
02-Jul-18 15:00RNSTotal Voting RightsHolding(s) in Company
02-Jul-18 07:00RNSImfinzi approved in Japan for Stage III nsclcCompany Announcement - General
02-Jul-18 07:00RNSLynparza approved in Japan for BRCAm breast cancerCompany Announcement - General
29-Jun-18 15:00RNSBydureon receives positive CHMP opinion for BCiseCompany Announcement - General
28-Jun-18 13:30RNSAZ and Luye Pharma complete agreement for SeroquelCompany Announcement - General
27-Jun-18 07:00RNSLynparza: significant PFS 1st-line ovarian cancerCompany Announcement - General
26-Jun-18 07:00RNSBoard Committee ChangesExecutive Changes
22-Jun-18 07:00RNSPublication of a ProspectusCompany Announcement - General
12-Jun-18 07:00RNSUpdate: lanabecestat Phase III Alzheimer's trialsCompany Announcement - General
08-Jun-18 17:30RNSEU APPROVES TAGRISSO FOR 1ST-LINE NSCLCCompany Announcement - General
08-Jun-18 07:00RNSDirector DeclarationExecutive Changes
01-Jun-18 15:00RNSBlock listing Interim ReviewCompany Announcement - General
01-Jun-18 15:00RNSTotal Voting RightsHolding(s) in Company
01-Jun-18 11:00RNSDirector DeclarationExecutive Changes
30-May-18 07:00RNSUpdate on TERRANOVA PIII trial for Fasenra in COPDCompany Announcement - General
25-May-18 07:00RNSAZ's Imfinzi: significant OS in Stage III nsclcCompany Announcement - General
21-May-18 07:00RNSAZ regulatory submission in Japan for ForxigaCompany Announcement - General
21-May-18 07:00RNSUS FDA approves Lokelma for adult hyperkalaemiaCompany Announcement - General
18-May-18 17:30RNSResult of AGMResults and Trading Reports
18-May-18 07:00RNSAZN: Q1 2018 ResultsResults and Trading Reports
11-May-18 07:00RNSAstraZeneca update on Fasenra PIII trial in COPDCompany Announcement - General
08-May-18 11:00RNSEMA approves Lynparza: maintenance ovarian cancerCompany Announcement - General
08-May-18 07:00RNSAZ and Luye Pharma enter agreement for SeroquelCompany Announcement - General
04-May-18 12:00RNSDirector DeclarationExecutive Changes
01-May-18 15:00RNSTotal Voting RightsHolding(s) in Company
27-Apr-18 12:30RNSAZ: positive CHMP for Tagrisso first-line nsclcCompany Announcement - General
24-Apr-18 07:00RNSAstraZeneca:high level results of the ARCTIC trialCompany Announcement - General
24-Apr-18 07:00RNSIssue of Equity - AstraZenecaCompany Announcement - General


Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.